13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 59 holding rows worth $604,294,540.
- Accession
- 0001214659-26-010311
- Filer
- CIK 1482416
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 59 entries on the cover page, a total value of $604,294,540 stated on the cover page (in dollars after the unit check, H1), rows summing to $604,294,540 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 5,545,984 | $54,627,942 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 173,588 | $49,121,932 | dollars as filed | |
| MAXIMUS INC | 577933104 | COM | 715,267 | $38,452,754 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 13,323,431 | $27,712,736 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 301,816 | $23,846,482 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 436,700 | $22,891,814 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 695,315 | $22,208,361 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 925,834 | $19,007,372 | dollars as filed | |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 1,230,700 | $18,165,132 | dollars as filed | put |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 480,383 | $17,903,874 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 177,118 | $16,856,320 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 57,750 | $15,920,520 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 364,200 | $15,536,772 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 88,186 | $15,318,790 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 954,299 | $15,154,268 | dollars as filed | |
| CROSS CTRY HEALTHCARE INC | 227483104 | COM | 1,098,393 | $14,509,772 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 307,657 | $12,820,067 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 128,656 | $11,674,245 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 110,022 | $11,510,502 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 131,445 | $11,316,100 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 18,000 | $11,223,720 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 193,500 | $11,149,470 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 142,500 | $11,147,775 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,075,274 | $10,957,042 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 1,592,692 | $9,046,491 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 623,130 | $8,910,759 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 1,300,000 | $8,593,000 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 97,305 | $8,054,908 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,921,872 | $7,341,551 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,003,562 | $6,944,649 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 208,500 | $6,517,710 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 1,486,175 | $6,182,488 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 59,254 | $5,776,080 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 127,808 | $5,622,274 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 539,493 | $5,297,821 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 208,557 | $5,293,177 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 73,952 | $5,191,430 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,078,965 | $4,920,080 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 617,675 | $3,804,878 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,634,137 | $3,529,744 | dollars as filed | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 369,036 | $3,162,639 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,005,334 | $2,704,348 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 124,168 | $2,631,120 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 75,000 | $2,600,250 | dollars as filed | call |
| AN2 THERAPEUTICS INC | 037326105 | COM | 529,933 | $2,564,876 | dollars as filed | |
| SERINA THERAPEUTICS INC | 81751A108 | COM SHS | 1,000,000 | $1,940,000 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 327,237 | $1,888,157 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 904,268 | $1,582,469 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 152,464 | $1,460,605 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 48,481 | $1,089,368 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 130,628 | $995,385 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 636,300 | $477,225 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 698,989 | $455,461 | dollars as filed | |
| NEUROONE MED TECHNOLOGIES CO | 64130M308 | COM | 82,767 | $251,612 | dollars as filed | |
| ENVERIC BIOSCIENCES INC | 29405E505 | COM SHS | 180,000 | $248,400 | dollars as filed | |
| Modular Medical, Inc. | 60785L306 | COM | 26,190 | $117,855 | dollars as filed | |
| QT IMAGING HLDGS INC | 746962307 | COM | 15,236 | $62,011 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $1,480 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $477 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-010311 | this filing | 2026-08-14 | acceptance time not in the bulk data set |